Acetylation and nitrosation of ciprofloxacin by environmental strains of mycobacteria

Canadian Journal of Microbiology

Volumn 53, Issue 1, 2007, Pages 144-147

  Adjei, Michael D ^a,b   Heinze, Thomas M ^a   Deck, Joanna ^a   Freeman, James P ^a   Williams, Anna J ^a   Sutherland, John B ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b Norfolk Department of Public Health   (United States)

Author keywords

Acetylation; Ciprofloxacin; Fluoroquinolones; Mycobacterium; Nitrosation

Indexed keywords

CIPROFLOXACIN; FLUOROQUINOLONES; MYCOBACTERIUM; NITROSATION;

ACETYLATION; DRUG PRODUCTS; ENVIRONMENTAL IMPACT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; YEAST;

BACTERIA;

ACETIC ACID ETHYL ESTER; CIPROFLOXACIN; DRUG METABOLITE; N ACETYLCIPROFLOXACIN; N NITROSOCIPROFLOXACIN; SORBITOL; UNCLASSIFIED DRUG;

ACETYLENE; ANTIBIOTICS; BACTERIUM; YEAST;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG ACETYLATION; DRUG TRANSFORMATION; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MYCOBACTERIUM; MYCOBACTERIUM FREDERIKSBERGENSE; MYCOBACTERIUM GILVUM; MYCOBACTERIUM SMEGMATIS; NITROSATION; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SUPERNATANT; YEAST;

ACETYLATION; ANTI-INFECTIVE AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; MAGNETIC RESONANCE SPECTROSCOPY; MYCOBACTERIA, ATYPICAL; NITROSATION;

CORYNEBACTERINEAE; MYCOBACTERIUM; MYCOBACTERIUM FREDERIKSBERGENSE; MYCOBACTERIUM GILVUM; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM SP.; MYCOBACTERIUM SP. 7; MYCOBACTERIUM SP. RJGII-135;

EID: 33846853262     PISSN: 00084166     EISSN: None     Source Type: Journal    
DOI: 10.1139/W06-101     Document Type: Article

References (32)

1. Adjei, M.D., Heinze, T.M., Deck, J., Freeman, J.P., Williams, A.J., and Sutherland, J.B. 2006. Transformation of the antibacterial agent norfloxacin by environmental mycobacteria. Appl. Environ. Microbiol. 72: 5790-5793.
2. Alangaden, G.J., and Lerner, S.A. 1997. The clinical use of fluoroquinolones for the treatment of mycobacterial diseases. Clin. Infect. Dis. 25: 1213-1221.
3. Burback, B.L., and Perry, J.J. 1993. Biodegradation and biotransformation of groundwater pollutant mixtures by Mycobacterium vaccae. Appl. Environ. Microbiol. 59: 1025-1029.
4. Calmels, S., Ohshima, H., Vincent, P., Gounot, A.-M., and Bartsch, H. 1985. Screening of microorganisms for nitrosation catalysis at pH 7 and kinetic studies on nitrosamine formation from secondary amines by E. coli strains. Carcinogenesis, 6: 911-915.
5. Calmels, S., Ohshima, H., and Bartsch, H. 1988. Nitrosamine formation by denitrifying and non-denitrifying bacteria: implication of nitrite reductase and nitrate reductase in nitrosation catalysis. J. Gen. Microbiol. 134: 221-226.
6. 1-nitrite reductase as one enzyme responsible for catalysis of nitrosation of secondary amines. Carcinogenesis, 17: 533-536.
7. 1H NMR. Biodegradation, 9: 433-442.
8. Edge, T.A., and Hill, S. 2005. Occurrence of antibiotic resistance in Escherichia coli from surface waters and fecal pollution sources near Hamilton, Ontario. Can. J. Microbiol. 51: 501-505.
9. Hearn, M.J., and Cynamon, M.H. 2003. In vitro and in vivo activities of acylated derivatives of isoniazid against Mycobacterium tuberculosis. Drug Des. Discovery, 18: 103-108.
10. Hein, D.W., Doll, M.A., Rustan, T.D., Gray, K., Feng, Y., Ferguson, R.J., and Grant, D.M. 1993. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases. Carcinogenesis, 14: 1633-1638.
11. Jacobs, M.R. 1999. Activity of quinolones against mycobacteria. Drugs, 58(Suppl. 2): 19-22.
12. Kakimoto, S., and Tone, I. 1965. Antituberculous compounds. XXIII. Alkyl- and acylisonicotinic acid hydrazides. J. Med. Chem. 8: 868.
13. Kelley, I., and Cerniglia, C.E. 1995. Degradation of a mixture of high-molecular-weight polycyclic aromatic hydrocarbons by a Mycobacterium strain PYR-1. J. Soil Contam. 4: 77-91.
14. Kunisaki, N., and Hayashi, M. 1979. Formation of N-nitrosamines from secondary amines and nitrite by resting cells of Escherichia coli B. Appl. Environ. Microbiol. 37: 279-282.
15. Lijinsky, M. 1999. N-Nitroso compounds in the diet. Mutat. Res. 443: 129-138.
16. Madan, A.K. 2004. Use of ciprofloxacin in the treatment of hospitalized patients with intra-abdominal infections. Clin. Ther. 26: 1564-1577.
17. Meyerhoff, A., Albrecht, R., Meyer, J.M., Dionne, P., Higgins, K., and Murphy, D. 2004. US Food and Drug Administration approval of ciprofloxacin hydrochloride for management of post-exposure inhalational anthrax. Clin. Infect. Dis. 39: 303-308.
18. Mills, A.L., and Alexander, M. 1976. N-Nitrosamine formation by cultures of several microorganisms. Appl. Environ. Microbiol. 31: 892-895.
19. Parshikov, I.A., Freeman, J.P., Lay, J.O., Beger, R.D., Williams, A.J., and Sutherland, J.B. 1999. Regioselective transformation of ciprofloxacin to N-acetylciprofloxacin by the fungus Mucor ramannianus. FEMS Microbiol. Lett. 177: 131-135.
20. Parshikov, I.A., Freeman, J.P., Lay, J.O., Moody, J.D., Williams, A.J., Beger, R.D., and Sutherland, J.B. 2001a. Metabolism of the veterinary fluoroquinolone sarafloxacin by the fungus Mucor ramannianus. J. Ind. Microbiol. Biotechnol. 26: 140-144.
21. Parshikov, I.A., Heinze, T.M., Moody, J.D., Freeman, J.P., Williams, A.J., and Sutherland, J.B. 2001b. The fungus Pestalotiopsis guepini as a model for biotransformation of ciprofloxacin and norfloxacin. Appl. Microbiol. Biotechnol. 56: 474-477.
22. Payton, M., Auty, R., Delgoda, R., Everett, M., and Sim, E. 1999. Cloning and characterization of arylamine N-acetyltransferase genes from Mycobacterium smegmatis and Mycobacterium tuberculosis: increased expression results in isoniazid resistance. J. Bacteriol. 181: 1343-1347.
23. Payton, M., Mushtaq, A., Yu, T.-W., Wu, L.-J., Sinclair, J., and Sim, E. 2001. Eubacterial arylamine N-acetyltransferases-identification and comparison of 18 members of the protein family with conserved active site cysteine, histidine and aspartate residues. Microbiology (Reading, U.K.), 147: 1137-1147.
24. Robicsek, A., Strahilevitz, J., Jacoby, G.A., Macielag, M., Abbanat, D., Park, C.H., Bush, K., and Hooper, D.C. 2006. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat. Med. 12: 83-88.
25. Saini, S.P.S., and Srivastava, A.K. 2001. The disposition kinetics, urinary excretion and dosage regimen of ciprofloxacin in buffalo calves (Bubalus bubalis). Vet. Res. Commun. 25: 641-649.
26. Sidgwick, N.V. 1966. The organic chemistry of nitrogen. 3rd ed. Edited by I.T. Millar and H.D. Springall. Clarendon Press, Oxford, England.
27. Tongpim, S., and Pickard, M.A. 1999. Cometabolic oxidation of phenanthrene to phenanthrene trans-9,10-dihydrodiol by Mycobacterium strain S1 growing on anthracene in the presence of phenanthrene. Can. J. Microbiol. 45: 369-376.
28. Upton, A., Johnson, N., Sandy, J., and Sim, E. 2001a. Arylamine N-acetyltransferases - of mice, men and microorganisms. Trends Pharmacol. Sci. 22: 140-146.
29. Upton, A.M., Mushtaq, A., Victor, T.C., Sampson, S.L., Sandy, J., Smith, D.-M., van Helden, P.V., and Sim, E. 2001b. Arylamine N-acetyltransferase of Mycobacterium tuberculosis is a polymorphic enzyme and a site of isoniazid metabolism. Mol. Microbiol. 42: 309-317.
30. Wolfson, J.S., and Hooper, D.C. 1985. The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro. Antimicrob. Agents Chemother. 28: 581-586.
31. Young, L.S., Berlin, O.G.W., and Inderlied, C.B. 1987. Activity of ciprofloxacin and other fluorinated quinolones against mycobacteria. Am. J. Med. 82: 23-26.
32. Ziebarth, D., Spiegelhalder, B., and Bartsch, H. 1997. N-Nitrosation of medicinal drugs catalysed by bacteria from human saliva and gastro-intestinal tract, including Helicobacter pylori. Carcinogenesis, 18: 383-389.